B

Bio-FD&C Co Ltd
KOSDAQ:251120

Watchlist Manager
Bio-FD&C Co Ltd
KOSDAQ:251120
Watchlist
Price: 13 270 KRW 2.47% Market Closed
Market Cap: 113.2B KRW
Have any thoughts about
Bio-FD&C Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

14.2
Current
18.1
Median
4.1
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
14.2
=
Enterprise Value
71.7B KRW
/
EBIT
5.1B KRW
All Countries
Close
EBIT Growth
KR
B
Bio-FD&C Co Ltd
KOSDAQ:251120
Average EV/EBIT: 21.3
14.2
71%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
12.9
2-Years Forward
EV/EBIT
10.9
3-Years Forward
EV/EBIT
8.4

See Also

Discover More